Crossmark

Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan

Crossref DOI link: https://doi.org/10.1038/s41409-022-01703-9

Published Online: 2022-05-28

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guijarro, Francesca https://orcid.org/0000-0001-6376-0929
Bataller, Alex https://orcid.org/0000-0002-6085-2745
Diaz-Beyá, Marina

Garrido, Ana

Coll-Ferrà, Christelle https://orcid.org/0000-0003-4571-5125
Vives, Susana

Salamero, Olga https://orcid.org/0000-0003-3237-0025
Valcárcel, David

Tormo, Mar https://orcid.org/0000-0001-9622-1649
Arnan, Montserrat

Sampol, Antònia https://orcid.org/0000-0001-7465-6203
Castaño-Díez, Sandra

Martínez, Carmen https://orcid.org/0000-0002-8401-7306
Suárez-Lledó, María

Fernández-Avilés, Francesc

Hernández-Boluda, Juan Carlos https://orcid.org/0000-0002-4289-3113
Ribera, Josep Maria

Rovira, Montserrat

Brunet, Salut

Sierra, Jorge https://orcid.org/0000-0002-7966-0356
Esteve, Jordi https://orcid.org/0000-0002-8056-648X
License Information

Text and Data Mining valid from 2022-05-28

Version of Record valid from 2022-05-28
More Information

Article History

Received: 19 March 2022

Revised: 25 April 2022

Accepted: 29 April 2022

First Online: 28 May 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below